 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
apoptosis
|
2 terms
|
 |
|
Biochemical function
|
cysteine-type peptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
98:14790-14795
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the activation of human procaspase-7.
|
|
S.J.Riedl,
P.Fuentes-Prior,
M.Renatus,
N.Kairies,
S.Krapp,
R.Huber,
G.S.Salvesen,
W.Bode.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Caspases form a family of proteinases required for the initiation and execution
phases of apoptosis. Distinct proapoptotic stimuli lead to activation of the
initiator caspases-8 and -9, which in turn activate the common executioner
caspases-3 and -7 by proteolytic cleavage. Whereas crystal structures of several
active caspases have been reported, no three-dimensional structure of an
uncleaved caspase zymogen is available so far. We have determined the 2.9-A
crystal structure of recombinant human C285A procaspase-7 and have elucidated
the activation mechanism of caspases. The overall fold of the homodimeric
procaspase-7 resembles that of the active tetrameric caspase-7. Each monomer is
organized in two structured subdomains connected by partially flexible linkers,
which asymmetrically occupy and block the central cavity, a typical feature of
active caspases. This blockage is incompatible with a functional substrate
binding site/active site. After proteolytic cleavage within the flexible
linkers, the newly formed chain termini leave the cavity and fold outward to
form stable structures. These conformational changes are associated with the
formation of an intact active-site cleft. Therefore, this mechanism represents a
formerly unknown type of proteinase zymogen activation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Occupancy of the central cavity by the blocking
segments. (A) Section of the dimer interface region,
superimposed with the well contoured lateral electron density
stretches accounting for the blocking segments Lys-320-Asp326,
and the disrupted central density (green). The final electron
density is contoured at 1.0 . The
main-chain segments are colored as in Fig. 2. The side chains of
some selected residues are shown as stick models. (B) Close-up
stereo view around the right-side blocking loop. The electron
density for residues Ile-321 to Asp-326 contoured at 1.0 is
superimposed.
|
 |
Figure 5.
Fig. 5. Schematic representation of the procaspase
activation mechanism. In the zymogen, both blocking segments and
part of the linker occupy the central cavity, preventing
intrusion of the elbow loop from the opposite monomer. Upon
activation cleavage, the newly formed N and C termini turn away
from the cavity crossing over each other to form stable
structures. This allows the elbow loop to expand into the now
empty cavity, enabling the substrate alignment segment to shift
and adopt its active conformation. As a consequence, the
substrate binding subsites and the active sites become
functional.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Boucher,
V.Blais,
M.Drag,
and
J.B.Denault
(2011).
Molecular determinants involved in activation of caspase 7.
|
| |
Biosci Rep, 31,
283-294.
|
 |
|
|
|
|
 |
J.A.Zorn,
and
J.A.Wells
(2010).
Turning enzymes ON with small molecules.
|
| |
Nat Chem Biol, 6,
179-188.
|
 |
|
|
|
|
 |
M.Lamkanfi,
and
T.D.Kanneganti
(2010).
Caspase-7: a protease involved in apoptosis and inflammation.
|
| |
Int J Biochem Cell Biol, 42,
21-24.
|
 |
|
|
|
|
 |
Q.P.Peterson,
D.R.Goode,
D.C.West,
R.C.Botham,
and
P.J.Hergenrother
(2010).
Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesis.
|
| |
Nat Protoc, 5,
294-302.
|
 |
|
|
|
|
 |
X.J.Wang,
Q.Cao,
X.Liu,
K.T.Wang,
W.Mi,
Y.Zhang,
L.F.Li,
A.C.LeBlanc,
and
X.D.Su
(2010).
Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation.
|
| |
EMBO Rep, 11,
841-847.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Pop,
and
G.S.Salvesen
(2009).
Human caspases: activation, specificity, and regulation.
|
| |
J Biol Chem, 284,
21777-21781.
|
 |
|
|
|
|
 |
J.A.Hardy,
and
J.A.Wells
(2009).
Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.
|
| |
J Biol Chem, 284,
26063-26069.
|
 |
|
|
|
|
 |
J.Gafni,
X.Cong,
S.F.Chen,
B.W.Gibson,
and
L.M.Ellerby
(2009).
Calpain-1 cleaves and activates caspase-7.
|
| |
J Biol Chem, 284,
25441-25449.
|
 |
|
|
|
|
 |
J.M.Elliott,
L.Rouge,
C.Wiesmann,
and
J.M.Scheer
(2009).
Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation.
|
| |
J Biol Chem, 284,
6546-6553.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.W.Yu,
P.D.Jeffrey,
and
Y.Shi
(2009).
Mechanism of procaspase-8 activation by c-FLIPL.
|
| |
Proc Natl Acad Sci U S A, 106,
8169-8174.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Walters,
C.Pop,
F.L.Scott,
M.Drag,
P.Swartz,
C.Mattos,
G.S.Salvesen,
and
A.C.Clark
(2009).
A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis.
|
| |
Biochem J, 424,
335-345.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.J.Wee,
J.C.Tong,
T.W.Tan,
and
S.Ranganathan
(2009).
A multi-factor model for caspase degradome prediction.
|
| |
BMC Genomics, 10,
S6.
|
 |
|
|
|
|
 |
S.L.Milam,
and
A.C.Clark
(2009).
Folding and assembly kinetics of procaspase-3.
|
| |
Protein Sci, 18,
2500-2517.
|
 |
|
|
|
|
 |
W.A.Witkowski,
and
J.A.Hardy
(2009).
L2' loop is critical for caspase-7 active site formation.
|
| |
Protein Sci, 18,
1459-1468.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Muscella,
N.Calabriso,
F.P.Fanizzi,
S.A.De Pascali,
L.Urso,
A.Ciccarese,
D.Migoni,
and
S.Marsigliante
(2008).
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway.
|
| |
Br J Pharmacol, 153,
34-49.
|
 |
|
|
|
|
 |
D.Siniscalco,
C.Giordano,
C.Fuccio,
L.Luongo,
F.Ferraraccio,
F.Rossi,
V.de Novellis,
K.A.Roth,
and
S.Maione
(2008).
Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats.
|
| |
Pharmacol Res, 57,
223-233.
|
 |
|
|
|
|
 |
J.C.Timmer,
and
G.S.Salvesen
(2007).
Caspase substrates.
|
| |
Cell Death Differ, 14,
66-72.
|
 |
|
|
|
|
 |
Q.Bao,
and
Y.Shi
(2007).
Apoptosome: a platform for the activation of initiator caspases.
|
| |
Cell Death Differ, 14,
56-65.
|
 |
|
|
|
|
 |
Q.Yin,
H.H.Park,
J.Y.Chung,
S.C.Lin,
Y.C.Lo,
L.S.da Graca,
X.Jiang,
and
H.Wu
(2006).
Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine.
|
| |
Mol Cell, 22,
259-268.
|
 |
|
|
|
|
 |
S.F.Larner,
R.L.Hayes,
and
K.K.Wang
(2006).
Unfolded protein response after neurotrauma.
|
| |
J Neurotrauma, 23,
807-829.
|
 |
|
|
|
|
 |
S.Huber,
A.Dohrman,
D.Sartini,
and
R.C.Budd
(2006).
Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein--long form-transgenic mice.
|
| |
Immunology, 119,
541-550.
|
 |
|
|
|
|
 |
F.L.Scott,
J.B.Denault,
S.J.Riedl,
H.Shin,
M.Renatus,
and
G.S.Salvesen
(2005).
XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.
|
| |
EMBO J, 24,
645-655.
|
 |
|
|
|
|
 |
H.Weiss,
A.Bleich,
H.J.Hedrich,
B.Kölsch,
M.Elsner,
A.Jörns,
S.Lenzen,
M.Tiedge,
and
D.Wedekind
(2005).
Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus.
|
| |
Mamm Genome, 16,
432-441.
|
 |
|
|
|
|
 |
K.Bose,
and
A.C.Clark
(2005).
pH effects on the stability and dimerization of procaspase-3.
|
| |
Protein Sci, 14,
24-36.
|
 |
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol, 21,
35-56.
|
 |
|
|
|
|
 |
S.F.Larner,
D.M.McKinsey,
R.L.Hayes,
and
K.K.W Wang
(2005).
Caspase 7: increased expression and activation after traumatic brain injury in rats.
|
| |
J Neurochem, 94,
97.
|
 |
|
|
|
|
 |
S.Piana,
Z.Taylor,
and
U.Rothlisberger
(2005).
Folding pathways for initiator and effector procaspases from computer simulations.
|
| |
Proteins, 59,
765-772.
|
 |
|
|
|
|
 |
Y.Chao,
E.N.Shiozaki,
S.M.Srinivasula,
D.J.Rigotti,
R.Fairman,
and
Y.Shi
(2005).
Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation.
|
| |
PLoS Biol, 3,
e183.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.A.Hardy,
J.Lam,
J.T.Nguyen,
T.O'Brien,
and
J.A.Wells
(2004).
Discovery of an allosteric site in the caspases.
|
| |
Proc Natl Acad Sci U S A, 101,
12461-12466.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.C.Subauste,
O.Pertz,
E.D.Adamson,
C.E.Turner,
S.Junger,
and
K.M.Hahn
(2004).
Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility.
|
| |
J Cell Biol, 165,
371-381.
|
 |
|
|
|
|
 |
S.J.Riedl,
and
Y.Shi
(2004).
Molecular mechanisms of caspase regulation during apoptosis.
|
| |
Nat Rev Mol Cell Biol, 5,
897-907.
|
 |
|
|
|
|
 |
S.Piana,
and
U.Rothlisberger
(2004).
Molecular dynamics simulations of structural changes during procaspase 3 activation.
|
| |
Proteins, 55,
932-941.
|
 |
|
|
|
|
 |
Y.Shi
(2004).
Caspase activation, inhibition, and reactivation: a mechanistic view.
|
| |
Protein Sci, 13,
1979-1987.
|
 |
|
|
|
|
 |
Y.Shi
(2004).
Caspase activation: revisiting the induced proximity model.
|
| |
Cell, 117,
855-858.
|
 |
|
|
|
|
 |
C.A.Ryan,
and
G.S.Salvesen
(2003).
Caspases and neuronal development.
|
| |
Biol Chem, 384,
855-861.
|
 |
|
|
|
|
 |
C.Z.Ni,
C.Li,
J.C.Wu,
A.P.Spada,
and
K.R.Ely
(2003).
Conformational restrictions in the active site of unliganded human caspase-3.
|
| |
J Mol Recognit, 16,
121-124.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.N.Shiozaki,
J.Chai,
D.J.Rigotti,
S.J.Riedl,
P.Li,
S.M.Srinivasula,
E.S.Alnemri,
R.Fairman,
and
Y.Shi
(2003).
Mechanism of XIAP-mediated inhibition of caspase-9.
|
| |
Mol Cell, 11,
519-527.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.M.Boatright,
and
G.S.Salvesen
(2003).
Mechanisms of caspase activation.
|
| |
Curr Opin Cell Biol, 15,
725-731.
|
 |
|
|
|
|
 |
K.M.Boatright,
M.Renatus,
F.L.Scott,
S.Sperandio,
H.Shin,
I.M.Pedersen,
J.E.Ricci,
W.A.Edris,
D.P.Sutherlin,
D.R.Green,
and
G.S.Salvesen
(2003).
A unified model for apical caspase activation.
|
| |
Mol Cell, 11,
529-541.
|
 |
|
|
|
|
 |
M.Donepudi,
A.Mac Sweeney,
C.Briand,
and
M.G.Grütter
(2003).
Insights into the regulatory mechanism for caspase-8 activation.
|
| |
Mol Cell, 11,
543-549.
|
 |
|
|
|
|
 |
M.Kalai,
M.Lamkanfi,
G.Denecker,
M.Boogmans,
S.Lippens,
A.Meeus,
W.Declercq,
and
P.Vandenabeele
(2003).
Regulation of the expression and processing of caspase-12.
|
| |
J Cell Biol, 162,
457-467.
|
 |
|
|
|
|
 |
M.Taveau,
N.Bourg,
G.Sillon,
C.Roudaut,
M.Bartoli,
and
I.Richard
(2003).
Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components.
|
| |
Mol Cell Biol, 23,
9127-9135.
|
 |
|
|
|
|
 |
S.R.Babu,
F.Bao,
C.M.Roberts,
A.K.Martin,
K.Gowan,
G.S.Eisenbarth,
and
P.R.Fain
(2003).
Caspase 7 is a positional candidate gene for IDDM 17 in a Bedouin Arab family.
|
| |
Ann N Y Acad Sci, 1005,
340-343.
|
 |
|
|
|
|
 |
V.R.Sutton,
M.E.Wowk,
M.Cancilla,
and
J.A.Trapani
(2003).
Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors.
|
| |
Immunity, 18,
319-329.
|
 |
|
|
|
|
 |
C.M.Troy,
and
G.S.Salvesen
(2002).
Caspases on the brain.
|
| |
J Neurosci Res, 69,
145-150.
|
 |
|
|
|
|
 |
Y.Shi
(2002).
Mechanisms of caspase activation and inhibition during apoptosis.
|
| |
Mol Cell, 9,
459-470.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|